These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4074453)

  • 1. Chylomicrons from patients with type V hyperlipoproteinemia inhibit platelet function.
    Aviram M; Furman B; Brook JG
    Atherosclerosis; 1985 Aug; 56(2):157-67. PubMed ID: 4074453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lipoprotein and platelet function after heparin injection: studies in normal fasted and postprandial and in type V hyperlipoproteinemic subjects.
    Aviram M; Rosenblat M; Potesman M; Dankner G; Brook JG
    Biochem Med Metab Biol; 1986 Jun; 35(3):279-92. PubMed ID: 3718760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipoprotein pattern and decreased platelet function in type V hyperlipoproteinemia.
    Aviram M; Brook JG
    Isr J Med Sci; 1985 Nov; 21(11):898-904. PubMed ID: 4077486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clq inhibition of the interaction of collagen with human platelets.
    Cazenave JP; Assimeh SN; Painter RH; Pachham MA; Mustard JF
    J Immunol; 1976 Jan; 116(1):162-3. PubMed ID: 1245737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chylomicron-like particles in severe hypertriglyceridemia.
    Aviram M; Sechter Y; Brook JG
    Lipids; 1985 Apr; 20(4):211-5. PubMed ID: 3999928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chylomicron-induced prothrombin activation and platelet aggregation.
    Xu N; Ohlin AK; Nilsson A
    Arterioscler Thromb; 1994 Jun; 14(6):1014-20. PubMed ID: 8199173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
    Gross PL; Rand ML; Barrow DV; Packham MA
    Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of aggregated immunoglobulins to the human platelet Fc receptors: a mechanism of platelet to platelet bridging.
    Parbtani A; Clark WF; Caveney A; Reid B
    Thromb Haemost; 1987 Dec; 58(4):966-70. PubMed ID: 3127922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of human plasma on platelet function in familial hypercholesterolemia.
    Aviram M; Brook GJ
    Thromb Res; 1982 Apr; 26(2):101-9. PubMed ID: 7112508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased in vitro platelet aggregation in hypertriglyceridemias.
    Riess H; Merk W; Falkner C; Hiller E
    Thromb Res; 1986 Feb; 41(3):281-9. PubMed ID: 3705010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of cytochalasin B on platelet release, aggregation and contractility: evidence against a contractile mechanism for the release of platelet granular contents.
    Kirkpatrick JP; McIntire LV; Moake JL; Cimo PL
    Thromb Haemost; 1980 Feb; 42(5):1483-9. PubMed ID: 6892735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
    Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
    Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of membrane anisotropy with function in subpopulations of human blood platelets.
    Raha S; Opper C; Wesemann W
    Br J Haematol; 1989 Jul; 72(3):397-401. PubMed ID: 2548563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a polyoxyethylene detergent (Brij 58) on platelet aggregation, release and clotting activity.
    Barton PG
    Biochim Biophys Acta; 1978 Feb; 539(1):98-113. PubMed ID: 623796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of phospholipase C and protein kinase C has little involvement in ADP-induced primary aggregation of human platelets: effects of diacylglycerols, the diacylglycerols, the diacylglycerol kinase inhibitor R59022, staurosporine and okadaic acid.
    Packham MA; Livne AA; Ruben DH; Rand ML
    Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):849-56. PubMed ID: 8384448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet function testing in the pony.
    Boudreaux MK; Wagner-Mann C; Purohit R; Hankes G; Spano J; Pablo L; Lee S; Conti J
    Lab Anim Sci; 1988 Aug; 38(4):448-51. PubMed ID: 3184855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation.
    Nimpf J; Wurm H; Kostner GM
    Atherosclerosis; 1987 Feb; 63(2-3):109-14. PubMed ID: 3827975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of VLDL, chylomicrons, and chylomicron remnants on platelet aggregability.
    Orth M; Luley C; Wieland H
    Thromb Res; 1995 Aug; 79(3):297-305. PubMed ID: 8533125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.